west china medical publishers
Keyword
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Keyword "抗癫痫药物" 40 results
  • 2023美国癫痫学会年会荟萃报道(一)

    美国癫痫学会(American Epilepsy Society,AES)年会是每年一度国际癫痫学界及工业界最受关注的会议。本年度的AES年会自2023年12月1日在奥兰多召开,为期5天,讨论了目前最受关注的癫痫学术领域及重点突破。本系列文章将分为五期,分别对大会每日的精彩内容进行荟萃报道:本文对大会第一日学术议程的内容进行了整理汇总,重点内容包括癫痫及癫痫持续状态药物治疗进展,癫痫认知相关共病,额叶癫痫,癫痫靶向治疗等。

    Release date:2024-03-07 01:49 Export PDF Favorites Scan
  • A Meta-analysis of effectiveness and safety of steroids combined with antiepileptic drugs in the treatment of children with epileptic electrical status during sleep

    ObjectiveTo systematically evaluate the efficacy of steroids combined with antiepileptic drugs compared with alone antiepileptic drugs in the treatment of children with epileptic electrical status during sleep to provide evidence-based medical basis for its treatment.MethodsElectronic searches were maded in PubMed, Embase database, Cochrane Library, CNKI, Wanfang and the Chinese biomedical literature database for the literature about steroids combined with antiepileptic drugs compared with alone antiepileptic drugs in the treatment, and retrieval time is from January 1990 to October 2020. Two evaluators independently screened literature, extracted data, evaluated literature quality and risk of bias and checked each other. Meta analysis was performed by stata16.0 software.ResultsA total of 679 children with ESES were included in 10 studies, including 9 randomized controlled trials and 1 retrospective cohort study. Meta analysis results showed that there were statistically significant differences in clinical improvement rate [RR=1.31, 95%CI (1.21, 1.42), P<0.01], electroencephalogram discharge improvement rate [RR=1.35, 95%CI (1.25, 1.46), P<0.01] and cognitive intelligence score [SMD=1.19, 95%CI (0.80, 1.57), P<0.01] between steroids combined with antiepileptic drugs group and alone antiepileptic drugs group after 6 months follow-up. The incidence of adverse reactions in steroids combined with antiepileptic drugs group was higher than that in alone antiepileptic drugs group, and the difference was statistically significant [RR=4.13, 95%CI (1.06, 16.13), P<0.01]. All adverse reactions improved or disappeared after drug withdrawal.ConclusionCompared with alone antiepileptic drugs, steroids combined with antiepileptic drugs group has advantages in controlling epileptic seizures, improving electroencephalogram abnormalities and improving cognitive ability, and it is relatively safe.

    Release date:2021-06-24 01:24 Export PDF Favorites Scan
  • 脑血管疾病继发癫痫:实验回顾和临床危险因素的荟萃分析

    癫痫发作可能发生在刚刚卒中发生以后或在很久以后。此外,癫痫也常发生在患有脑白质疏松的患者。尽管卒中后早期痫性发作被广泛研究,卒中后癫痫(Post-stroke epilepsy,PSE)和与脑白质疏松相关癫痫(Epilepsy associated with leukoaraiosis,EAL)研究较少。文章目的是回顾PSE和EAL相关病理生理学,预后和治疗情况。并进行了广泛的文献检索,以筛选关于PSE和EAL的动物实验和临床文章。同时,还对纳入研究中PSE和EAL发生的风险因素进行了系统的回顾分析。PSE是由于瘢痕组织内和其附近神经元兴奋性增加引起的。白质改变在EAL中的作用尚待阐明。荟萃分析显示皮质受累[ OR=3.71,95% CI (2.34, 5.90),P < 0.001],脑出血[ OR=2.41,95% CI (1.57, 3.70),P < 0.001]和早期痫性发作[ OR=4.43,95% CI (2.36, 8.32),P < 0.001]显著增加PSE发生风险。关于EAL,没有前瞻性、基于人群的研究评估不同变量对癫痫发作风险的影响。关于PSE治疗的研究相对有限。PSE药物控制效果通常良好。有关危险因素、预后和EAL治疗的资料较缺乏。PSE的病理生理学和危险因素是明确的,但在EAL中仍需进一步阐明。PSE和EAL的治疗依赖于临床医生的判断,并应在个人基础上进行调控。

    Release date:2017-05-24 05:46 Export PDF Favorites Scan
  • 抗癫痫药物对颈内动脉内膜剥脱术后脑高灌注综合征的防治体会

    目的探讨颈内动脉内膜剥脱术(CEA)围手术期应用抗癫痫药物对防治CEA后脑高灌注综合征(CHS)的效果。 方法选择2012年4月-10月有CHS危险因素的CEA患者75例,随机分为治疗组(37例)和对照组(38例)。对照组患者应用抗血小板药物、他汀类药物治疗,治疗组患者在对照组的基础上,于术前3 d开始口服丙戊酸钠缓释片,观察其术后1周、3个月的临床表现。 结果治疗组患者术后1周出现CHS相关表现11例(29.7%),无癫痫发作(0.0%);术后3个月CHS相关表现全部消失,仍无癫痫发作。对照组患者术后1周出现CHS相关表现23例(60.5%),癫痫发作3例(7.9%);术后3个月后13例(35.1%)仍有轻度CHS相关表现,无癫痫发作。两组比较差异有统计学意义(P < 0.05)。 结论围手术期应用抗癫痫药物可有效降低CEA后出现CHS相关表现和癫痫发作概率。

    Release date:2016-10-28 02:02 Export PDF Favorites Scan
  • 抗癫痫药物与骨折风险

    癫痫是神经系统的一种常见疾病,药物治疗是癫痫治疗的首选方法。由于癫痫病程长,患者常常需要长期服药甚至终身服药,药物长期服用的安全性是必须考虑的。有研究显示癫痫患者的骨折风险是普通人群的2~6倍,长期服用抗癫痫药物(AEDs)是导致骨折风险增加的独立危险因素。不同类型的AEDs对不同年龄阶段人群的骨代谢有不同的影响,应根据不同年龄选择合适的药物。如何预防骨折是癫痫专科医生应该关心的问题,应注意监测相关指标,防止骨折的发生。

    Release date:2017-09-26 05:09 Export PDF Favorites Scan
  • 自身免疫性脑炎癫痫相关临床特征的研究进展

    自身免疫性脑炎(Autoimmune encephalopathies,AE)指一类由自身免疫机制介导的脑炎,其主要临床表现为情绪、性格改变,记忆力下降,精神行为异常及癫痫发作。其中癫痫发作是AE常见的症状之一,对于某些类型的AE有特征性表现,文章针对AE相关癫痫的临床表现、脑电图特征及抗癫痫治疗等方面,总结了近年来自身免疫性脑炎相关癫痫的主要研究进展。

    Release date:2017-11-27 02:36 Export PDF Favorites Scan
  • The effect of medication withdraw on long-term electroencephalogram monitoring in children who need preoperative assessment for refractory epilepsy

    PurposeTo analyze the effect of medication withdraw (MW) on long-term electroencephalogram (EEG) monitoring in children who need preoperative assessment for refractory epilepsy.MethodsRetrospective analysis was performed on the data of preoperative long-term EEG monitoring of children with refractory epilepsy who needed preoperative evaluation in the Pediatric Epilepsy Center of Peking University First Hospital from August 2018 to December 2019. Monitoring duration: at least three habitual seizures were detected, or the monitoring duration were as long as 10 days. MW protocol was according to the established plan.ResultsA total of 576 children (median age 4.4 years) required presurgical ictal EEGs, and 75 (75/576, 13.0%) needed MW for ictal EEGs. Among the 75 cases, 38 were male and 37 were female. The age range was from 15 months to 17 years (median age: 7.0 years). EEG and clinical data of with 65 children who strictly obey the MW protocol were analyzed. The total monitoring duration range was from 44.1 h (about 2 days) to 241.8 h (about 10 days)(median: 118.9 h (about 5 days)). Interictal EEG features before MW were including focal interictal epileptiform discharge (IED) in 39 cases (39/65, 60%), focal and generalized IED in 2 cases (2/65, 3.1%), multifocal IED in 20 cases (20/65, 30.7%), multifocal and generalized IED in 2 cases (2/65, 3.1%), and no IED in 2 cases (2/65, 3.1%). After MW, 18 cases (18/65, 27.7%) had no change in IED and the other 47 cases had changes of IED after MW. And IEDs in 46 cases (46/65, 70.8%) were aggravated, and IED was decreased in 1 case. The pattern of aggravated IED was original IED increasement, in 41 cases (41/46, 89.1%), and 5 cases (5 /46, 10.9%) had generalized IED which was not detected before MW. Of the 46 patients with IED exacerbations, 87.3% appeared within 3 days after MW. Habitual seizures were detected in 56 cases (86.2%, 56/65) after MW, and within 3 days of MW in 80.4% cases. Eight patients (14.3%) had secondary bilateral-tonic seizure (BTCS), of which only 1 patient had no BTCS in his habitual seizures. In 56 cases, 94.6% (53/56) had seizures after MW of two kinds of AEDs.Conclusions① In this group, thirteen percent children with intractable epilepsy needed MW to obtain ictal EEG; ② Most of them (86.2%) could obtain ictal EEG by MW. The IED and ictal EEG after MW were still helpful for localization of epileptogenic zone; ③ Most of the patients can obtain ictal EEG within 3 days after MW or after MW of two kinds of AEDs;4. The new secondary generalization was extremely rare.

    Release date:2021-04-25 09:50 Export PDF Favorites Scan
  • 基于文献回顾及临床经验的欧洲专家意见:丙戊酸在女童和育龄期女性癫痫患者中的使用意见

    丙戊酸(Valproate,VPA)是一种广谱抗癫痫药物(Antiepileptic drugs,AEDs),相较于其他 AEDs,其对儿童癫痫综合征和特发性全面性癫痫(Idiopathic generalized epilepsy,IGE)更为有效。2018 年,欧洲药品管理局(European Medicines Agency,EMA)就 VPA 在女童和育龄期女性中的使用颁布了全新的限制条例,以避免患者在妊娠期间暴露于 VPA。此次对现有限制条例的进一步加强在患者和医学界中引发了广泛的争议和讨论。在育龄期女性中,仍有很大比例的癫痫综合征患者在使用 VPA,此外,VPA 替代药物的致畸信息缺乏,均为如何管理此类患者带来了不确定性。在本意见声明中,欧洲癫痫专家组基于文献回顾和临床经验,提出了针对不同癫痫类型的女童、育龄期女性和孕妇 AEDs 治疗的综合建议。

    Release date:2021-04-25 09:50 Export PDF Favorites Scan
  • Analysis of the factors of recurrence after discontinuation of antiepileptic drugs in the first year in children with idiopathic epilepsy

    ObjectiveTo observe the children with idiopathic epilepsy who received AED therapy and seizure-free, withdrawal at least 1 year, and analyze the risk factors of seizure recurrence. In order to give better instructions for AED withdrawal of children with idiopathic epilepsy in pediatric department. MethodsChildren with idiopathic epilepsy who were seizure-free and had stopped AED treatment at least 1 year before the deadline of observation were collected from pediatric outpatient and inpatient department of the First Affiliated Hospital of Guangxi Medical University from January 2011 to January 2014. The following variables, derived from the case records were analyzed: sex, age at seizure onset, type of seizure, time period between the onset of the first seizure and start of treatment, number of seizures in the time period between the start of AED therapy and the last seizure, number of AEDs before remission, time period between the start of AED therapy and the last seizure, time period between the last seizure and withdrawal of AED treatment (seizure-free period, timing of AED withdrawal), time period between the start of AED withdrawal and total discontinuation(speed of withdrawal), EEG registered at the time of diagnosis, before AED withdrawal, during and after AED withdrawal, and the condition of recurrence, data analysed by multi-variate step-wise Cox regression model analysis. ResultsA total of 16(12.8%) children relapsed in a total number of 125 children with idiopathic epilepsy we collected; date evaluated by multi-variable analysis showed that the children suffering from seizure type of focal seizure, starting withdrawal after a seizure-free period of less than 3 years and with abnormal post-withdrawal EEG recording was associated with a higher risk of seizure recurrence. ConclusionsChildren with idiopathic epilepsy have a low risk of recurrence after AED withdrawal. Those who suffer from seizure type of focal seizure, start withdrawal after a seizure-free period of less than 3 years and with abnormal post-withdrawal EEG recording are associated with a higher risk of seizure recurrence.

    Release date: Export PDF Favorites Scan
  • Ⅲ期临床试验非盲延期阶段联合使用吡仑帕奈的局灶性癫痫患者的四年药物安全性、耐受性及发作结局:307 号研究

    评估 307 号研究(临床试验验证码:NCT00735397)Ⅲ期非盲延期阶段(OLEx)联合使用吡仑帕奈的局灶性癫痫患者的药物安全性、耐受性及痫性发作结局。患者在完成任一 III 期双盲试验后均可进入非盲延期阶段(Open-labelextension,OLEx)。对所有 OLEx 队列中有同样最小吡伦帕奈暴露剂量的局灶性癫痫和继发全面性癫痫(Secondarily generalized seizures,SGS)的患者进行药物安全性及耐受性和痫性发作结局(每 28 d 中位痫性发作减少率、反应率和无发作率)的分析。另外,针对 OLEx 的早期失访进行了额外的敏感性分析。从 1 480 例双盲试验中随机分组的患者共纳入 1 218 例。大部分患者(65.4%~80.9%)仅用吡仑帕奈 12 mg,每日一次,进行治疗,并在相同剂量下完成长期的检测,或是相对基线联合使用少量抗癫痫药物(AEDs)。长期的药物安全性及耐受性结果与双盲研究一致。导致超过 1% 的患者研究中断治疗的紧急不良反应事件(Treatment-emergent adverse events,TEAEs)包括眩晕、易激、疲劳。有临床意义的 TEAEs 稳定期为 4 年。所有队列中患者的痫性发作结局随时间持续改善。对于接受 3 年(n = 436)、4 年(n = 78)药物治疗的患者 28 d 中位痫性发作减少率分别为 62%、70.6%,相应的 50% 反应率为 59.6%、67.9%。最大 28 d 中位痫性发作减少率发生于基线水平的 SGS 患者,接受 3 年(n = 190)、4 年(n = 28)药物治疗分别为 88.0% 和 100.0%。在这些队列中分别有 40.0% 和 53.6% 的患者达到了无 SGS。排除早期失访后的 28 d 中位痫性发作减少率结果类似。长期吡仑帕奈联合用药(≤4 年)不会导致新的药物安全性及耐受性问题,并且可以很大程度地减少痫性发作,特别是基线水平的 SGS 患者。

    Release date:2020-03-20 08:06 Export PDF Favorites Scan
4 pages Previous 1 2 3 4 Next

Format

Content